Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging

NCT01436604 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT01436604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01436604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging
Lead sponsor
Centre Francois Baclesse
Phase
Phase 2
Overall status
Terminated
Start date
February 29, 2012
Completion date
May 31, 2017
Enrollment
19 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, breast, lv dysfunction